Clinical Trials Review Panel

A panel of experts has been assembled to review the applications submitted to this competition.
Ian Thompson, Chair University of Texas Health Science Center at San Antonio
San Antonio, TX, USA
Brian Davis Mayo Clinic
Rochester, MN, USA
Maha Hussain University of Michigan Comprehensive Cancer Center
Ann Arbor, MI, USA
Daniel Lin University of Washington
Seattle, WA, USA
David Penson Vanderbilt University Medical Center
Nashville, TN, USA
David Quinn University of Southern California Keck School of Medicine
Los Angeles, CA, USA
Catherine Tangen Fred Hutchinson Cancer Research Center
Seattle, WA, USA
Melanie Walker, Scientific Officer Queen's University
Kingston, ON
Walter Eadie, Community Representative Oakville, ON
Winston Klass, Community Representative Concord, ON

Note: This list will be updated as additional panel members are recruited.

Donate Now!

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.

Click here for news archive